Search

Your search keyword '"Miquel Aguilar"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Miquel Aguilar" Remove constraint Author: "Miquel Aguilar"
107 results on '"Miquel Aguilar"'

Search Results

1. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease

2. Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease

3. Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease

4. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

5. Predictors of clinically significant quality of life impairment in Parkinson’s disease

6. Validity and sensitivity of instrumented postural and gait assessment using low-cost devices in Parkinson’s disease

7. Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease

8. Heritability and genetic variance of dementia with Lewy bodies

9. A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders

10. Motor Fluctuations Development Is Associated with Non-Motor Symptoms Burden Progression in Parkinson’s Disease Patients: A 2-Year Follow-Up Study

11. Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

12. Neuropsychological Outcome One Year after Carotid Revascularization: A before-and-after Study

13. Predictors of Loss of Functional Independence in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up and Comparison with a Control Group

14. El 'Llibre de l'orde de cavalleria' en el context sociocultural medieval

15. La reescritura de la leyenda de Tristán e Iseo en 'Cligès'

16. Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease.

17. Motius folklòrics al Tristany i Iseut

18. Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease

19. In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study

20. Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study

21. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

22. Intermediate and Expanded <scp> HTT </scp> Alleles and the Risk for α‐Synucleinopathies

23. Smoking is associated with age at disease onset in Parkinson's disease

24. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men

25. GWAS for CSF TREM2 levels identify new variants implicated on TREM2 biology and Alzheimer disease

26. Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies

27. Association between LAG3/CD4 gene variants and risk of Parkinson's disease

28. Mendelian randomization confirms the role of Y-chromosome loss in Alzheimer’s Disease etiopathogenesis in males

29. Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia

30. Nuevos datos normativos de la versión española de la Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) forma A

31. New normative data from the Spanish-language version of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), form A

32. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group

33. Guia d’abordatge del delírium

34. <scp>COPPADIS</scp> ‐2015 ( <scp>CO</scp> hort of Patients with PArkinson's <scp>DI</scp> sease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

35. Clinical and genetic characteristics of late-onset Huntington's disease

36. Mood in Parkinson's disease: From early- to late-stage disease

37. Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis

38. Validity and sensitivity of instrumented postural and gait assessment using low-cost devices in Parkinson's disease

39. Genome-wide association, Mendelian Randomization and polygenic risk score studies converge on a role of β−amyloid and APOE locus in Parkinson disease

40. Association between the missense alcohol dehydrogenase rs1229984T variant with the risk for Parkinson’s disease in women

41. Systematic Screening of Ubiquitin/p62 Aggregates in Cerebellar Cortex Expands the Neuropathological Phenotype of the C9orf72 Expansion Mutation

42. Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression

43. Caregiver burden in Parkinsonʼs disease

44. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

45. Nigral and striatal connectivity alterations in asymptomaticLRRK2mutation carriers: A magnetic resonance imaging study

46. Relationship between quadriceps thickness measured by ultrasound and nutritional status at admission for hip fracture

47. A comprehensive screening of copy number variability in dementia with Lewy bodies

48. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study

49. Heritability and genetic variance of dementia with Lewy bodies

50. No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients

Catalog

Books, media, physical & digital resources